Cantor Fitzgerald’s AstraZeneca AZN Stock Holding History

Cantor Fitzgerald’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-74,113	Closed	-$11.5M	–	284
2024 Q3	$11.5M	Buy	74,113 +66,851	+921%	+$10.8M	0.33%	20
2024 Q2	$1.13M	Buy	+7,262	New	+$1.09M	0.22%	70
2024 Q1	–	Sell	-40,886	Closed	-$5.51M	–	279
2023 Q4	$5.51M	Buy	+40,886	New	+$5.32M	1.13%	17
2023 Q3	–	Sell	-8,152	Closed	-$1.17M	–	560
2023 Q2	$1.17M	Buy	+8,152	New	+$1.2M	0.03%	289
2023 Q1	–	Sell	-277,185	Closed	-$37.6M	–	675
2022 Q4	$37.6M	Buy	277,185 +106,848	+63%	+$13.4M	0.81%	20
2022 Q3	$18.7M	Buy	+170,337	New	+$21.6M	0.41%	58

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Cantor Fitzgerald's AZN Position: Q4 2024 in Review

Cantor Fitzgerald sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 74,113 shares — an estimated $11.5M sold.

Cantor Fitzgerald first reported a position in AZN in Q3 2022 and held it in 6 quarters. The position peaked at $37.6M in Q4 2022. 1,218 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

Cantor Fitzgerald reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
Cantor Fitzgerald sold 74,113 AstraZeneca shares in Q4 2024, an estimated $11.5M.
Cantor Fitzgerald first reported a position in AstraZeneca in Q3 2022 and held it in 6 quarters.
Cantor Fitzgerald's AstraZeneca position peaked at $37.6M in Q4 2022.
1,218 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Cantor Fitzgerald's 13F filing for Q4 2024, filed 14 Feb 2025.